![]() |
| News Releases | |
Bode Technology Group to Identify Victims at World Trade
Center SPRINGFIELD, VA. - October 1, 2001 - Bode Technology Group, a ChoicePoint company (NYSE: CPS) and the nation's largest private forensic DNA testing lab, has entered into agreements with both the State of New York and New York City to perform DNA testing in an effort to identify the victims of the attack on the World Trade Center. In addition, Bode will provide quality assurance testing of work performed by third-party labs. "Like the rest of the country, we at ChoicePoint mourn the loss of the thousands of lives from around the world. We're ready to support the efforts to help families bring closure in their lives," said Derek Smith, CEO and chairman of ChoicePoint. Bode's agreement with the state includes the analysis of 30,000 DNA samples from victims or provided by families using short tandem repeat (STR) technology and 1,000 of the more sensitive mitochondrial DNA (MTDNA) tests. The MTDNA process can be more successful in obtaining results from samples exposed to intense heat and decomposition. Bode is the only private lab involved in the World Trade Center DNA identification effort with forensic mass disaster experience that routinely performs both STR and MTDNA testing in a forensic setting. "This is the largest mass disaster DNA identification effort ever undertaken," explained Mitchell Holland, Ph.D., the lab director at Bode, who was involved in the DNA identification efforts for TWA Flight 800, Alaska Air, and Egypt Air airline disasters. "The magnitude of this disaster just cannot be compared." Bode currently supports nine state-mandated convicted offender DNA databases and multiple efforts to reduce the backlog of sexual offense evidence kits. The company also performs criminal DNA casework and advanced research on DNA identification techniques. About the Bode Technology Group Privacy
|